Difference between revisions of "Aminopterin"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "Category:Discontinued" to "Category:Discontinued drugs") |
m |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 4: | Line 4: | ||
==Diseases for which it was used== | ==Diseases for which it was used== | ||
| − | *[[B-cell acute lymphoblastic leukemia]] | + | *[[B-cell acute lymphoblastic leukemia - historical|B-cell acute lymphoblastic leukemia]] |
| + | |||
| + | ==Also known as== | ||
| + | *'''Generic name:''' 4-aminopteroyl-glutamic acid | ||
[[Category:Drugs]] | [[Category:Drugs]] | ||
| Line 12: | Line 15: | ||
[[Category:Antifolates]] | [[Category:Antifolates]] | ||
| − | [[Category:B-cell acute lymphoblastic leukemia medications]] | + | [[Category:B-cell acute lymphoblastic leukemia medications (historic)]] |
[[Category:Investigational drugs]] | [[Category:Investigational drugs]] | ||
[[Category:Discontinued drugs]] | [[Category:Discontinued drugs]] | ||
Latest revision as of 12:30, 4 December 2022
General information
Class/mechanism: Folate analog, antimetabolite, interferes with DNA synthesis. Discontinued due to concerns about toxicity, manufacturing difficulties, and rough equivalence to methotrexate. It remains under investigation for the non-neoplastic condition of psoriasis.
Route: IM
Diseases for which it was used
Also known as
- Generic name: 4-aminopteroyl-glutamic acid